By 2029, the company is expected to report more than $670 million in sales, according to FactSet.IBD 50 Biotech StockGeneDx stock has largely trended sideways over recent months in the wake of a first ...

Cells depend on the precise reading of DNA sequences to function correctly. This process, known as gene expression, ...

There is more movement in our genome than we think. Almost half of the human genome consists of transposons – short DNA ...

Enhanced Genomics and The ALBORADA Drug Discovery Institute are now exploring opportunities to expand their partnership to other neurodegenerative diseases. The company is also open to partnerships ...

As of 17 June 2025, there have been over 4,000 confirmed cases of mpox and 25 deaths in Sierra Leone, raising the possibility ...

In diseases due to exposure to toxic particles like gout, macrophages elicit separate pathways for inflammation and lysosomal ...

B y the end of the next 10 years, the UK’s National Health Service (NHS) is aiming to test the DNA of every baby born, as ...

A new study has examined brains affected by PTSD at the single-cell level, uncovering distinct genetic alterations that may ...

Currently, new parents are offered a blood spot test for their babies, normally when the child is five days old, to check whether they have any of nine rare, but serious, conditions. The newborn’s ...

A recent study published in Engineering has provided novel insights into the involvement of α2,6-sialylation in Alzheimer's ...

GeneDx Holdings Corp. leverages genomics leadership with robust growth, despite recent stock challenges. Click for more on ...